Back to Top Skip to main content Skip to sub-navigation

Navy unit provided COVID-19 support to Peruvian First Responders

Fireman getting COVID test in firehouse garage Bombero physician collects sample for testing at the Bellavista Fire Station No. 60 in Callao, Peru. (Courtesy Photo.)

Recommended Content:

Coronavirus | Global Health Engagement | COVID-19 Vaccine Toolkit

U.S. Naval Medical Research Unit Number 6 (NAMRU-6) recently provided COVID-19 support to the Bellavista Fire Station No. 60 in Callao, Peru.

Responding to a reported COVID-19 exposure among the Bellavista Fire Station No. 60 firefighters, NAMRU-6 tested 45 de-identified, coded samples from firefighters with a possible exposure to individuals with confirmed cases SARS-CoV-2, the virus responsible for COVID-19 infection.

The testing performed by NAMRU-6 is based upon the detection of the virus’ nucleic acids through a sensitive method known as Real Time Reverse Transcriptase- Polymerase Chain Reaction. Results identified samples that showed detectable levels of the virus and were provided to fire station leadership the same day. Collaborating with the fire station medical and safety staff allowed immediate isolation of infected individuals to prevent further COVID-19 spread among emergency workers. 

The province of Callao has the second highest number of COVID-19 cases in Peru, and the implementation of infection control measures remains a critical component to slowing the spread of the virus. Through the foresight of the Bellavista Fire Station leadership and the swift response of NAMRU-6 scientists, Bellavista Fire Station No. 60 could continue their critical mission, which includes providing first responder support to the U.S. Navy lab.

The Bellavista Fire Station No. 60 is located on the Centro Médico Naval installation in Callao, which is where the NAMRU-6 compound is also located. The fire station has been supporting the lab dating back to 2009 when NAMRU-6 leadership identified gaps in emergency management response and annual exercises. NAMRU-6 requested firefighting and rescue response support from the fire station and the relationship became official in the NAMRU-6 Emergency Management Plan. The partnership currently supports annual exercises in emergency scenarios such as fire in a laboratory, large-scale chemical spills, large-scale biological spills, rescue of injured personnel, and health emergencies such as a heart attack. 

“The ability to provide a critical service to our Peruvian partners underscores the collaborative effort that NAMRU-6 seeks with all our partners, especially during this unprecedented global crisis,” said U.S. Navy Cmdr. Michael Prouty, deputy research science director at NAMRU-6.

NAMRU-6 Safety Director Roberto Cosio mentioned, “The firemen participate as first responders and provide basic life support or initial emergency aid to injured people. The molecular testing provided to the firemen not only helped prevent the spread of COVID-19 to their coworkers and families, but also the individuals they assist on a daily basis.”

The Peruvian Navy hosts NAMRU-6 at their flagship hospital in Lima, and naval clinics in Iquitos and Puerto Maldonado. NAMRU-6 conducts research on and surveillance of a wide range of infectious diseases of military and public health significance in the region; and anti-microbial resistance monitoring.

“As the host of NAMRU-6 for the past 37 years, the Peruvians have provided us with immeasurable support in advancing our infectious disease research mission,” said U.S. Navy Capt. William Howard, NAMRU-6 commanding officer. “When we received the request from the Bellavista Firefighters, we were more than happy to be able to help with the testing and continue our longstanding friendship.”

You also may be interested in...

Get to Know the Vaccines

Publication
9/17/2021

A graphic showing the types of vaccines, how they work, and safety monitoring of the vaccines. Includes the MHS and TRICARE logos on the bottom right, and includes graphics of scientists, doctors, and patients.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines

Get to know the COVID19 Vaccines

Publication
9/17/2021

Get to know the vaccines – they do not contain the live virus, they do not interact with our DNA, and have been tested rigorously.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines

Line Leader Presentation (PDF)

Publication
8/4/2021

This document is identical to the PowerPoint presentation for line leader reference and use.

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Line Leader Presentation (Powerpoint)

Publication
8/4/2021

Leaders across the Department can leverage this briefing deck to discuss COVID-19 vaccines with their troops. Don't forget to reference speaker notes and to personalize the title slide!

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

VAX Facts about Getting the COVID Vaccine at the Same Time as Others

Publication
6/9/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

Get to Know the COVID-19 Vaccines (Combined)

Publication
6/9/2021

The Pfizer-BioNTech, Moderna, and Janssen (Johnson & Johnson) COVID-19 vaccines were developed to prevent infection from the virus that causes COVID-19. Learn about the vaccines, how they work and safety precautions.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | Getting the COVID-19 Vaccine | COVID-19 Vaccine Efforts

COVID-19 Vaccine Safety Monitoring

Publication
6/9/2021

The FDA and CDC continue to monitor the safety of COVID-19 vaccines. CDC has an independent group of experts that reviews all the safety data as it comes in and provides regular safety updates.

Recommended Content:

Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Toolkit | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

Get to Know the COVID-19 Vaccines

Publication
6/9/2021

The Pfizer-BioNTech, Moderna, and Janssen (Johnson & Johnson) COVID-19 vaccines were developed to prevent infection from the virus that causes COVID-19.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

How COVID-19 Vaccines Work

Publication
6/9/2021

Learn how the different COVID-19 vaccines work.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

Airborne Hazards and Open Burn Pit Registry User Guide for Service Members

Publication
6/1/2021

The following guide is designed to help service members navigate the complete registry process. It describes the registry requirements; provides an in-depth, step-by-step guide for accessing, registering, and completing the Airborne Hazards and Open Burn Pit Registry questionnaire; and provides instructions for scheduling the optional, in-person medical exam.

Recommended Content:

Coronavirus | Airborne Hazards and Open Burn Pit Registry | Environmental Exposures

COVID-19 Vaccine Leader Card

Publication
5/27/2021

This printable card provides talking points when discussing the COVID-19 vaccine with servicemembers who are reluctant or indifferent to accepting the vaccine. The card lists common concerns and impressions, top 5 key messages, and supporting facts about the vaccine.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vax Facts

Unit Leader Vaccine Conversation Guide

Publication
5/24/2021

This guide offers approaches and illustrative examples for preparation, delivery, and navigation of small group discussions (recommended 1-5 people to facilitate greatest engagement) with servicemembers reluctant or indifferent to accepting the vaccine. The guide promotes an open dialogue regarding vaccine hesitancy and complacency by addressing concerns, building trust, and boosting vaccine confidence.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vax Facts

Provider Vaccine Conversation Guide

Publication
5/24/2021

This guide offers approaches and illustrative examples for Military Health System (MHS) providers to discuss the COVID-19 vaccine with servicemembers during routine visits. Initiating a COVID-19 vaccine conversation during servicemember visits will allow you to effectively address concerns, build trust, and boost vaccine confidence.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vax Facts

COVID-19 Vaccine Approved for Adolescents Ages 12 and Over

Publication
5/13/2021

The Pfizer-BioNTech vaccine is approved for those ages 12 and over. Includes a photo of adolescents at the top of the page, has the TRICARE logo at the bottom right. Links in the content include www.TRICARE.mil/VaccineAppointments and www.Vaccines.gov.

Recommended Content:

COVID-19 Vaccine Toolkit | Vaccine Eligibility

VAX Facts How Long does Protection Last?

Publication
4/21/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vax Facts
<< < 1 2 3 4 5 > >> 
Showing results 1 - 15 Page 1 of 5

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.